Fundz
Real-time · AI · Cross-signal

PrognomiQ just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on PrognomiQ, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

PrognomiQ Announces Partnership with Seer, Inc. for $34 Million Series D Financing

Nov 05, 2024•over 1 year ago

Contract Type

partnership

San MateoBiotechnologyHealth CareScience And Engineering

Description

PrognomiQ has announced a partnership with Seer, Inc. for a $34 million Series D financing. The financing will be used to advance the development of an early detection test for lung cancer.

Company Information

Company

PrognomiQ

Location

San Mateo, California, United States

About

PrognomiQ aims to generate proteomic information with high accuracy, scale and speed. This proteomic data will be complemented with genomic, metabolomic and other health information to deliver first-in-class test products that enable early disease detection and treatment.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for PrognomiQ's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months